Kinnevik (KINV) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
21 Oct, 2025Executive summary
NAV increased 2% to SEK 37.5bn (3% in constant FX), driven by strong operational performance in core companies and selective investments in Mews, Enveda, Aira, and Nory, with SEK 1,015m invested in Q3 and SEK 2,675m in the first nine months.
Core companies averaged 35% revenue growth and 2 percentage point EBITDA margin improvement year-to-date, with lead indicators pointing to a strong 2026.
Net cash position at SEK 8.6bn, reflecting a robust financial profile and limited follow-on investment needs.
Significant investments included EUR 15m in Mews, USD 150m raised by Enveda, and EUR 150m by Aira, with new portfolio addition Nory.
Financial highlights
Q3 2025 net profit of SEK 741m, reversing a loss of SEK 1,913m in Q3 2024; NAV per share at SEK 135.56, up from SEK 132.87 in Q2 2025.
Private investments up 3% to SEK 28.9bn; public investments down 3% to SEK 888m.
73% of the private portfolio is profitable or financed to break-even under current plans.
Core companies represent 51% of the portfolio, with underlying valuations up 2% on average.
Change in fair value of financial assets in Q3 was SEK 731m, mainly from unlisted holdings.
Outlook and guidance
Portfolio maturity trend expected to persist, supporting stability and focused capital allocation, with larger companies growing with disciplined margin control and funding needs declining.
Lead indicators and operational performance suggest continued positive momentum into 2026.
Investment pipeline focused on opportunities that reinforce portfolio maturity and optionality for monetization and liquidity.
Limited capital needs in the portfolio, with a disciplined and opportunistic investment approach.
Latest events from Kinnevik
- NAV fell 4% in Q4 and 8% for 2025 as market headwinds offset strong core company growth.KINV
Q4 20253 Feb 2026 - NAV fell 4.7–5% as core growth companies outperformed and capital deployment set to rise.KINV
Q2 20243 Feb 2026 - Strong portfolio growth offset by 15–20% valuation headwinds from market and currency shifts.KINV
Pre-silent presentation26 Jan 2026 - NAV fell 5% to SEK 37.4bn as VillageMD was written down, but core assets grew over 60%.KINV
Q3 202419 Jan 2026 - Focused on high-growth private assets in health, software, and climate tech, targeting 15–25%+ returns.KINV
CMD 202419 Jan 2026 - NAV up 5% to SEK 39.2bn, core companies grew 55%, strong SEK 10.9bn net cash for growth.KINV
Q4 20249 Jan 2026 - NAV up 2% to SEK 36.8bn, core revenue growth >35%, SEK 860m invested, SEK 9.6bn net cash.KINV
Q2 20258 Jan 2026 - NAV down 8% as core companies delivered >40% revenue growth and strong cash position.KINV
Q1 202524 Dec 2025 - Q3 2025 featured higher investment activity and selective portfolio growth amid mild valuation declines.KINV
Pre-Silent Presentation2 Oct 2025